Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

CHOP-Style Chemotherapy for Canine Lymphoma: Protocol Discussion Profile
CHOP is a family of veterinary lymphoma protocols built around cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine and prednisone. Exact sequence, dose and duration vary by oncology service and patient.
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read more
Named profile Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic BiologicRepresentative category illustration – no product packaging is shown.Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic Biologic
Oncept is a USDA-listed canine melanoma DNA biologic; license status, specialist access, intended setting, evidence limitations, and cost require current review.
Read more
Named profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile
gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label ProfileRepresentative category illustration – no product packaging is shown.Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label Profile
feline interleukin-2 recombinant canarypox virus (vCP1338) is covered as veterinary biologic immunotherapy used with surgery and radiotherapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a…
Read more